26
October

11:00 AM EST

ArisGlobal Virtual Boardroom

The Future Is Now – Key Objectives and Strategies for Making Sense of Pharmacovigilance Data and Driving Deeper Strategic Insights

Join us to discover:

Join this roundtable for an insightful conversation with your industry peers. Examine the latest trends and strategies influencing how leading firms are leveraging data and analytics to drive greater patient safety and operational efficiencies. Learn what business challenges and priorities are shaping investment objectives and timelines. Discover what other leaders are focusing on as they evolve their safety programs. Share your perspectives and gain valuable insights from firms that have seen results and with innovation initiatives underway.

Online Agenda

Why you should attend

The virtual boardroom is limited to 25 participants only. Each participant shall have the opportunity to raise questions and vividly contribute to the discussion.

Meet the Facilitator

The virtual boardroom will be lead by our expert facilitator:

Beena Wood

VP, Safety Product Management ArisGlobal

Beena Wood has been in the Information technology space building products for over 26 years, with experience across multiple domains. She has led Engineering as well as Product Management 
teams. She comes from Oracle where she was in the Pharmacovigilance space for over 15 years, leading their Argus Safety Product Management teams, and most recently from Anju Software leading their Medical Affairs space, and loves building solutions to keep patients safe. She is excited to be part of <a href="https://www.arisglobal.com/">ArisGlobal</a> team and feels fortunate being part of something that matters 
to human lives. Beena lives in Portland in the beautiful Pacific NW, with her husband, a young daughter who loves to read, write, and dance, and a mini labradoodle. Beena’s passion, apart from 
being part of Life sciences solutions that keeps patients safe, is to help kids that doesn’t have the means to have better access to education, loves the ocean and hikes with her family, and to meditate.

Emmanuel Belabe

Associate Vice President of Solution Consulting ArisGlobal

More about ArisGlobal

More information

ArisGlobal is transforming the way today’s most successful Life Sciences companies develop breakthroughs and bring new products to market. Our end-to-end drug development technology platform, LifeSphere®, integrates our proprietary cognitive computing engine to automate all core functions of the drug development lifecycle. Designed with deep expertise and a long-term perspective that spans more than 30 years, LifeSphere® is a unified platform that boosts efficiency, ensures compliance, delivers actionable insights, and lowers total cost of ownership through multi-tenant SaaS architecture. Headquartered in the United States, ArisGlobal has regional offices in Europe, India, Japan and China.

Further Information

Interested in attending this virtual roundtable or running your own? Drop us a message today and we will get in touch.

Europe

USA East

USA West

Webinars

Dinners & Spotlights

R&D

Clinical Trials ArisGlobal

ArisGlobal Virtual Boardroom – 13th April 2022

ArisGlobal Virtual Boardroom

Online Agenda

Realizing the strategic opportunity of data and analytics in pharmacovigilance today

Bringing together diverse sources of structured and unstructured healthcare data

Transforming data into intelligence through advancements in automation and analytics

Achieving greater patient safety by enabling global teams to action insights in real-time

Why you should attend

Meet the Facilitator

Beena Wood

Emmanuel Belabe

More about ArisGlobal

Further Information

Select days you wish to attend You can add multiple days

VAT Excluded

Select days you wish to attend You can add multiple days

Pass includes:

VAT Excluded

About You

Your Address

About Your Company

This is required field*

Bone/Osteoporosis

Immunology

Orthopaedics

Cardiovascular

Infectious diseases

Pulmonology

CNS

Inflammation

Psychiatry

Dermatology

Internal diseases

Respiratory

Diabetes

Metabolic diseases

Rheumatology

Endocrinology

Nephrology

Surgery

ENT

Neurology

Urology

Gastroenterology

Oncology

Vaccines

Haematology

Ophthalmology

Thrombosis

Rare Diseases

This is required field*

0-10

10-50

50-100

100-500

500+

This is required field*

This is required field*

Under £100,000

£100,000 - £500,000

£500,000 - £1,000,000

£1,000,000 - £5,000,000

£5,000,000 - £10,000,000

£10,000,000 +

This is required field*

This is required field*

Discovery to Development

Pre-Clinical

Phase 1

Phase 2

Phase 3

Phase 4

This is required field*